Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial

NAEnrolling by invitationINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions

Ventilator-Associated Pneumonia (VAP)

Interventions

DRUG

Beta Lactam Antibiotics

Beta lactam cefipim infusion (20mg/kg -12h -2 days ) total volume 10 ml

DRUG

Salin

Patient will receive .9 % saline (10ml /12h/2days)

Trial Locations (1)

Benha university hospital, Banhā

All Listed Sponsors

lead

Esraa Salah Mohamed Abdallah Eladl

OTHER